Nevertheless, BCR is considered a primary sign of PC progression and a more aggressive course of the disease, although its accurate diagnosis utilizing routine PSA levels in the serum is generally perplexing and may lead to poor patient outcomes. This evidence concerns the gene BCR and pachyonychia congenita.